The goal of this concept is to generate comprehensive evidence to determine whether immunotherapeutic strategies, including broadly neutralizing antibodies (bNAbs) and antibody-derived constructs, can safely and effectively target HIV persistence within the central nervous system (CNS) compartment while mitigating neuroimmune dysfunction and improving mental health outcomes.
Source: nimh